Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Serological And Molecular Tests On Dbs

Research Leaders

8 sponsors active, led by CIRDES

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT03356665Not ApplicableCompleted

Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP2 Passive Case Detection

Showing all 1 trials

Research Network

Common Treatments

  • Serological And Molecular Tests On Dbs1
  • Rapid Diagnostic Test Rdt1

Active Sponsors

  • CIRDES1
  • Institut de Recherche pour le Developpement1
  • Institut National de Sante Publique1
  • Ministry of Health, Guinea1
  • Institute of Tropical Medicine, Belgium1

Top Investigators

Related Conditions

  • African Trypanosomiases1
  • Sleeping Sickness West African1
  • Trypanosoma Brucei Gambiense Infection1

Activity Timeline